Table 3. Reverse Amide SAR.

| entry | R | rat mGlu1 pIC50 (±SEM)a | rat mGlu1 IC50 (nM) | rat % Glu Max (±SEM)ab | human mGlu1 pIC50 (±SEM)a | human mGlu1 IC50 (nM) | human % Glu Max (±SEM)ab |
|---|---|---|---|---|---|---|---|
| 23 | N-phenyl | 5.92 ± 0.10 | 1190 | 4.8 ± 1.7 | <4.5 | >30 000 | |
| 24 | N-methyl-N-phenyl | <4.5 | >30 000 | <4.5 | >30 000 | ||
| 25 | N-2-fluorophenyl | 6.64 ± 0.10 | 230 | 2.5 ± 0.7 | <4.5 | >30 000 | |
| 26 | N-2-chlorophenyl | 5.93 ± 0.18 | 1180 | 2.2 ± 0.6 | <4.5 | >30 000 | |
| 27 | N-2-methylphenyl | <5.0c | >10 000 | 21.1 ± 7.7 | <4.5 | >30 000 | |
| 28 | N-3-fluorophenyl | 6.11 ± 0.17 | 768 | 9.5 ± 3.3 | <4.5 | >30 000 | |
| 29 | N-3-chlorophenyl | 6.35 ± 0.03 | 443 | 58.9 ± 12.3 | <4.5 | >30 000 | |
| 30 | N-3-methylphenyl | 5.74 ± 0.25 | 1830 | 1.1 ± 0.8 | <5.0c | >10 000 | 69.9 ± 2.7 |
| 31 | N-4-fluorophenyl | 5.96 ± 0.01 | 1100 | 31.8 ± 3.1 | <4.5 | >30 000 | |
| 32 | N-isopropyl | <5.0c | >10 000 | 19.3 ± 8.2 | <4.5 | >30 000 | |
| 33 | N-cyclohexyl | 5.80 ± 0.02 | 1570 | 5.4 ± 0.4 | <4.5 | >30 000 | |
| 34 | N-(trans)-4-methylcyclohexyl | <4.5 | >30 000 | <4.5 | >30 000 | ||
| 35 | N-cycloheptyl | <5.0c | >10 000 | 20.7 ± 5.6 | <4.5 | >30 000 | |
| 36 | (R)-N-1-cyclohexylethyl | <5.0c | >10 000 | 62.0 ± 5.2 | <4.5 | >30 000 | |
| 37 | (S)-N-1-cyclohexylethyl | <5.0c | >10 000 | 16.9 ± 7.8 | <4.5 | >30 000 | |
| 38 | N-3,3-dimethylbutyl | 6.13 ± 0.05 | 735 | 3.1 ± 0.4 | <5.0c | >10 000 | 70.0 ± 3.1 |
Values are average of n ≥ 3.
Amplitude of response in the presence of 30 μM test compound as a percentage of maximal response (100 μM glutamate); average of n ≥ 3.
CRC does not plateau.